SeaStar Medical
ICU
26 hedge funds and large institutions have $205K invested in SeaStar Medical in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.61% less ownership
Funds ownership: 1.04% → 0.43% (-0.61%)
86% less capital invested
Capital invested by funds: $1.5M → $205K (-$1.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$105K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$56.1K |
| 3 |
VF
Virtu Financial
New York
|
+$43.6K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$11.5K |
| 5 |
TFA
Trinity Financial Advisors
Columbus,
Ohio
|
+$5.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.02M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$6.7K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$346 |
| 4 |
CAWM
Capital A Wealth Management
New Castle,
Pennsylvania
|
-$239 |
| 5 |
Morgan Stanley
New York
|
-$69 |
ICU Hedge Fund Activity: Q2 2025 in Review
26 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q2 2025, worth a combined $205K — down 86% from $1.5M a quarter earlier.
Fund positioning in ICU was balanced in Q2 2025: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $105K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.02M sold.
- 26 institutional investors held SeaStar Medical (ICU) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $205K of SeaStar Medical stock for Q2 2025, down 86% quarter-over-quarter.
- 2 funds opened new SeaStar Medical positions in Q2 2025 and 2 closed out, a net change of 0 holders.
- The largest SeaStar Medical buyer in Q2 2025 was UBS Group, an estimated $105K added.
- The largest SeaStar Medical seller in Q2 2025 was Armistice Capital, an estimated $1.02M sold.
Based on aggregated 13F filings for Q2 2025.